By Bachem AG
To get in touch with Bachem AG, simply fill out the form below.
Subscribe to Supplier
Bachem featuring CMC development of peptides and oligos at BioMed Israel
Bubendorf, Switzerland: –Peptide technology specialist Bachem will once more be a high-profile presence at one of the Mideast Region’s leading life sciences events, the Biomed Israel conference in Tel Aviv in early May.
Bachem will be an exhibitor at the event with a stand at Booth 42 in the expo zone at the David Intercontinental Hotel. Displays will showcase Bachem’s considerable strengths in developing and GMP manufacturing of peptides and oligonucleotides, based on its long-term expertise in chemistry manufacturing and controls (CMC) development.
The Bachem team at Biomed 2022 will include Federica Decò, Business Development Manager and Georgios Georgopoulos, Business Development Manager, who will also talk about Bachem’s ability to manufacture generic commercial APIs, diagnostic and cosmetic peptides and its huge range of research substances.
This is a return to Biomed Israel for Bachem, following a two year pause enforced by the coronavirus pandemic, opening up new opportunities to connect with local partners and customers.
Bachem is a leading, innovation-driven company specializing in the development and manufacture of peptides and oligonucleotides. With over 50 years of experience and expertise, Bachem provides products for research, clinical development and commercial application to pharmaceutical and biotechnology companies worldwide and offers a comprehensive range of services.
Bachem operates internationally with headquarters in Switzerland and locations in Europe, the US and Asia. The company is listed on the SIX Swiss Exchange. For further information, see www.bachem.com.
About Biomed Israel 2022
Founded in 2002, the Biomed Israel Conference and Exhibition has become one of the most important life sciences events for the MENA (Middle East and North Africa) Region.
The 20th Anniversary conference is a three-day event, opening May 10 at the David Intercontinental Hotel in Tel Aviv. The conference will maintain the focus on diagnosis, monitoring and treatment domains from previous meetings but for 2022 will expand the agenda to explore trends and innovations shaping the future of healthcare systems.
Specific discussions will include Medical Devices, Biopharma, Digital Health and Diagnosis, with specific conference tracks covering topics such as Cell, Gene and Nucleic Acids Therapies, Transformative Precision Cancer Diagnostics and Therapies, AI and Machine Learning, Digital Reconstruction of Healthcare, Infectious Diseases and Vaccine Development, and roles for Robotics in medicine.
Biomed 2022 is organized by Kenes Exhibitions on behalf of leading Israeli and international healthcare institutions with further information at: https://kenes-exhibitions.com/biomed